TSHA Financial Statements

Balance sheet, income statement, cash flow, and dividends for Taysha Gene Therapies Inc (TSHA).


$354.55M Market Cap.

As of 02/26/2025 5:00 PM ET (MRY) • Disclaimer

TSHA Market Cap. (MRY)


TSHA Shares Outstanding (MRY)


TSHA Assets (MRY)


Total Assets

$160.36M

Total Liabilities

$88.84M

Total Investments

$0

TSHA Income (MRY)


Revenue

$8.33M

Net Income

-$89.30M

Operating Expense

$99.79M

TSHA Cash Flow (MRY)


CF Operations

-$81.22M

CF Investing

-$363.00K

CF Financing

$76.68M

TSHA Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

TSHA Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$160,364,000 (-7.16%)

$172,731,000 (36.79%)

$126,276,000 (-40.98%)

$213,956,000 (-17.35%)

Assets Current

$142,130,000 (-5.16%)

$149,868,000 (55.44%)

$96,417,000 (-39.59%)

$159,602,000 (-38.11%)

Assets Non-Current

$18,234,000 (-20.25%)

$22,863,000 (-23.43%)

$29,859,000 (-45.07%)

$54,354,000 (5324.55%)

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Shareholders Equity

$71,525,000 (-4.55%)

$74,937,000 (7796.42%)

$949,000 (-99.01%)

$95,383,000 (-62.04%)

Property Plant & Equipment Net

$15,866,000 (-22.26%)

$20,408,000 (-21.22%)

$25,906,000 (-48.81%)

$50,610,000 (17534.15%)

Cash & Equivalents

$141,636,000 (-3.35%)

$146,540,000 (61.89%)

$90,517,000 (-40.35%)

$151,740,000 (-39.61%)

Accumulated Other Comprehensive Income

-$4,031,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Deferred Revenue

$9,773,000 (-46.02%)

$18,106,000 (-46.04%)

$33,557,000 (0%)

$0 (0%)

Total Investments

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Payables

$3,592,000 (-43.58%)

$6,366,000 (-41.84%)

$10,946,000 (-49.70%)

$21,763,000 (991.42%)

Accumulated Retained Earnings (Deficit)

-$602,305,000 (-17.41%)

-$513,007,000 (-27.79%)

-$401,441,000 (-70.36%)

-$235,649,000 (-285.51%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$61,303,000 (3.10%)

$59,461,000 (1.80%)

$58,407,000 (57.04%)

$37,192,000 (0%)

Debt Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Debt Non-Current

$61,303,000 (3.10%)

$59,461,000 (1.80%)

$58,407,000 (57.04%)

$37,192,000 (0%)

Total Liabilities

$88,839,000 (-9.16%)

$97,794,000 (-21.97%)

$125,327,000 (5.70%)

$118,573,000 (1464.49%)

Liabilities Current

$26,227,000 (-28.65%)

$36,756,000 (-41.46%)

$62,790,000 (21.34%)

$51,746,000 (625.85%)

Liabilities Non-Current

$62,612,000 (2.58%)

$61,038,000 (-2.40%)

$62,537,000 (-6.42%)

$66,827,000 (14750.44%)

TSHA Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$8,333,000 (-46.07%)

$15,451,000 (517.55%)

$2,502,000 (0%)

$0 (0%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$28,953,000 (-3.64%)

$30,047,000 (-19.57%)

$37,360,000 (-9.59%)

$41,324,000 (271.99%)

Research & Development Expense

$66,001,000 (16.24%)

$56,778,000 (-37.72%)

$91,169,000 (-30.90%)

$131,943,000 (313.71%)

Operating Expenses

$99,792,000 (13.54%)

$87,890,000 (-46.72%)

$164,949,000 (-4.80%)

$173,267,000 (302.93%)

Interest Expense

$102,000 (-97.96%)

$4,998,000 (31.60%)

$3,798,000 (165.97%)

$1,428,000 (5000.00%)

Income Tax Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$89,298,000 (19.96%)

-$111,566,000 (32.80%)

-$166,014,000 (4.88%)

-$174,523,000 (-190.82%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$89,298,000 (19.96%)

-$111,566,000 (32.80%)

-$166,014,000 (4.88%)

-$174,523,000 (-190.82%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$89,298,000 (19.96%)

-$111,566,000 (32.80%)

-$166,014,000 (4.88%)

-$174,523,000 (-190.82%)

Weighted Average Shares

$250,134,421 (115.41%)

$116,121,482 (164.20%)

$43,952,015 (16.74%)

$37,650,566 (113.13%)

Weighted Average Shares Diluted

$250,134,421 (115.41%)

$116,121,482 (164.20%)

$43,952,015 (16.74%)

$37,650,566 (113.13%)

Earning Before Interest & Taxes (EBIT)

-$89,196,000 (16.30%)

-$106,568,000 (34.30%)

-$162,216,000 (6.28%)

-$173,095,000 (-188.57%)

Gross Profit

$8,333,000 (-46.07%)

$15,451,000 (517.55%)

$2,502,000 (0%)

$0 (0%)

Operating Income

-$91,459,000 (-26.26%)

-$72,439,000 (55.41%)

-$162,447,000 (6.24%)

-$173,267,000 (-302.93%)

TSHA Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$363,000 (95.06%)

-$7,352,000 (70.51%)

-$24,930,000 (-15.66%)

-$21,554,000 (-137.33%)

Net Cash Flow from Financing

$76,684,000 (-43.78%)

$136,393,000 (161.81%)

$52,097,000 (33.30%)

$39,083,000 (-86.57%)

Net Cash Flow from Operations

-$81,225,000 (-11.24%)

-$73,018,000 (17.39%)

-$88,390,000 (24.48%)

-$117,042,000 (-280.88%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$4,904,000 (-108.75%)

$56,023,000 (191.51%)

-$61,223,000 (38.48%)

-$99,513,000 (-139.61%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Capital Expenditure

-$374,000 (90.33%)

-$3,869,000 (81.24%)

-$20,619,000 (-34.73%)

-$15,304,000 (-18563.41%)

Issuance (Repayment) of Debt Securities

-$18,000 (99.53%)

-$3,849,000 (0%)

$0 (0%)

$39,957,000 (0%)

Issuance (Purchase) of Equity Shares

$76,869,000 (-45.43%)

$140,858,000 (163.30%)

$53,497,000 (0%)

$0 (0%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$13,103,000 (65.76%)

$7,905,000 (-56.19%)

$18,043,000 (-0.78%)

$18,184,000 (442.16%)

Depreciation Amortization & Accretion

$2,462,000 (-3.56%)

$2,553,000 (2.65%)

$2,487,000 (405.49%)

$492,000 (5366.67%)

TSHA Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

100.00% (0.00%)

100.00% (0.00%)

100.00%

-

Profit Margin

-1071.60% (-48.40%)

-722.10% (89.12%)

-6635.30%

-

EBITDA Margin

-1040.80% (-54.60%)

-673.20% (89.46%)

-6384.10%

-

Return on Average Equity (ROAE)

-110.60% (-106.50%)

1700.80% (344.61%)

-695.30% (-542.61%)

-108.20% (-126.36%)

Return on Average Assets (ROAA)

-51.50% (36.34%)

-80.90% (33.47%)

-121.60% (-63.66%)

-74.30% (-60.13%)

Return on Sales (ROS)

-1070.40% (-55.20%)

-689.70% (89.36%)

-6483.50%

-

Return on Invested Capital (ROIC)

-179.50% (85.18%)

-1211.60% (-337.09%)

-277.20% (62.70%)

-743.10% (97.75%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-4.81 (-160.63%)

-1.84 (-208.36%)

-0.6 (76.18%)

-2.51 (67.83%)

Price to Sales Ratio (P/S)

51.93 (290.39%)

13.3 (-66.49%)

39.7

-

Price to Book Ratio (P/B)

4.96 (12.25%)

4.42 (-97.03%)

148.7 (3064.57%)

4.7 (17.83%)

Debt to Equity Ratio (D/E)

1.24 (-4.83%)

1.3 (-99.01%)

132.06 (10524.46%)

1.24 (4043.33%)

Earnings Per Share (EPS)

-0.36 (62.50%)

-0.96 (74.60%)

-3.78 (18.53%)

-4.64 (-36.47%)

Sales Per Share (SPS)

0.03 (-75.19%)

0.13 (133.33%)

0.06 (0%)

0 (0%)

Free Cash Flow Per Share (FCFPS)

-0.33 (50.76%)

-0.66 (73.31%)

-2.48 (29.45%)

-3.52 (-101.55%)

Book Value Per Share (BVPS)

0.29 (-55.66%)

0.65 (2831.82%)

0.02 (-99.13%)

2.53 (-82.19%)

Tangible Assets Book Value Per Share (TABVPS)

0.64 (-56.92%)

1.49 (-48.21%)

2.87 (-49.45%)

5.68 (-61.22%)

Enterprise Value Over EBIT (EV/EBIT)

-3 (-50.00%)

-2 (-100.00%)

-1 (50.00%)

-2 (83.33%)

Enterprise Value Over EBITDA (EV/EBITDA)

-2.94 (-37.96%)

-2.13 (-139.71%)

-0.89 (46.09%)

-1.65 (86.33%)

Asset Turnover

0.05 (-57.14%)

0.11 (522.22%)

0.02 (0%)

0 (0%)

Current Ratio

5.42 (32.92%)

4.08 (165.43%)

1.54 (-50.19%)

3.08 (-91.47%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$81,599,000 (-6.13%)

-$76,887,000 (29.47%)

-$109,009,000 (17.63%)

-$132,346,000 (-329.54%)

Enterprise Value (EV)

$254,985,919 (15.04%)

$221,653,542 (56.15%)

$141,949,555 (-50.13%)

$284,620,459 (-60.66%)

Earnings Before Tax (EBT)

-$89,298,000 (19.96%)

-$111,566,000 (32.80%)

-$166,014,000 (4.88%)

-$174,523,000 (-190.82%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$86,734,000 (16.61%)

-$104,015,000 (34.88%)

-$159,729,000 (7.46%)

-$172,603,000 (-187.80%)

Invested Capital

$53,804,000 (10.04%)

$48,896,000 (55.84%)

$31,376,000 (-34.17%)

$47,662,000 (9451.50%)

Working Capital

$115,903,000 (2.47%)

$113,112,000 (236.37%)

$33,627,000 (-68.82%)

$107,856,000 (-56.99%)

Tangible Asset Value

$160,364,000 (-7.16%)

$172,731,000 (36.79%)

$126,276,000 (-40.98%)

$213,956,000 (-17.35%)

Market Capitalization

$354,551,919 (7.14%)

$330,919,542 (134.50%)

$141,119,555 (-68.52%)

$448,221,459 (-55.28%)

Average Equity

$80,759,750 (1331.14%)

-$6,559,750 (-127.47%)

$23,877,500 (-85.20%)

$161,286,000 (28.43%)

Average Assets

$173,493,250 (25.80%)

$137,910,750 (1.02%)

$136,513,000 (-41.89%)

$234,921,750 (81.48%)

Invested Capital Average

$49,689,000 (464.90%)

$8,796,000 (-84.97%)

$58,524,000 (151.24%)

$23,293,750 (12698.76%)

Shares

204,943,306 (9.62%)

186,960,193 (199.41%)

62,442,281 (62.30%)

38,473,945 (1.89%)